Literature DB >> 12780686

Insight into antibody responses induced by plasmid or adenoviral vectors encoding thyroid peroxidase, a major thyroid autoantigen.

J Guo1, P Pichurin, Y Nagayama, B Rapoport, S M McLachlan.   

Abstract

Plasmid and adenoviral vectors have been used to generate antibodies in mice that resemble human autoantibodies to the thyrotrophin receptor. No such studies, however, have been performed for thyroid peroxidase (TPO), the major autoantigen in human thyroiditis. We constructed plasmid and adenovirus vectors for in vivo expression of TPO. BALB/c mice were immunized directly by intramuscular injection of TPO-plasmid or TPO-adenovirus, as well as by subcutaneous injection of dendritic cells (DC) infected previously with TPO-adenovirus. Intramuscular TPO-adenovirus induced the highest, and TPO-plasmid the lowest, TPO antibody titres. Mice injected with TPO-transfected DC developed intermediate levels. Antibodies generated by all three approaches had similar affinities (Kd approximately 10(-9)M) and recognized TPO expressed on the cell-surface. Their epitopes were analysed in competition assays using monoclonal human autoantibodies that define the TPO immunodominant region (IDR) recognized by patients with thyroid autoimmune disease. Surprisingly, high titre antibodies generated using adenovirus interacted with diverse TPO epitopes largely outside the IDR, whereas low titre antibodies induced by DNA-plasmid recognized restricted epitopes in the IDR. This inverse relationship between antibody titre and restriction to the IDR is likely to be due to epitope spreading following strong antigenic stimulation provided by the adenovirus vector. However, TPO antibody epitope spreading does not occur in Hashimoto's thyroiditis, despite high autoantibody levels. Consequently, these data support the concept that in human thyroid autoimmunity, factors besides titre must play a role in shaping an autoantibody epitopic profile.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12780686      PMCID: PMC1808732          DOI: 10.1046/j.1365-2249.2003.02170.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

Review 1.  Autoimmune response to the thyroid in humans: thyroid peroxidase--the common autoantigenic denominator.

Authors:  S M McLachlan; B Rapoport
Journal:  Int Rev Immunol       Date:  2000       Impact factor: 5.311

2.  Targeting the replication of adenovirus to p53-defective thyroid carcinoma with a p53-regulated Cre/loxP system.

Authors:  Y Nagayama; E Nishihara; H Namba; H Yokoi; M Hasegawa; H Mizuguchi; T Hayakawa; H Hamada; S Yamashita; M Niwa
Journal:  Cancer Gene Ther       Date:  2001-01       Impact factor: 5.987

3.  Thyroid autoimmunity.

Authors:  B Rapoport; S M McLachlan
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

4.  A full biological response to autoantibodies in Graves' disease requires a disulfide-bonded loop in the thyrotropin receptor N terminus homologous to a laminin epidermal growth factor-like domain.

Authors:  C R Chen; K Tanaka; G D Chazenbalk; S M McLachlan; B Rapoport
Journal:  J Biol Chem       Date:  2001-02-08       Impact factor: 5.157

Review 5.  Modulation of immune responses to DNA vaccines by codelivery of cytokine genes.

Authors:  C H Pan; H W Chen; M H Tao
Journal:  J Formos Med Assoc       Date:  1999-11       Impact factor: 3.282

6.  Does the autoantibody immunodominant region on thyroid peroxidase include amino acid residues 742-771?

Authors:  Z Xiong; L Farilla; J Guo; S McLachlan; B Rapoport
Journal:  Thyroid       Date:  2001-03       Impact factor: 6.568

7.  A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.

Authors:  Yuji Nagayama; Masako Kita-Furuyama; Takao Ando; Kazuhiko Nakao; Hiroyuki Mizuguchi; Takao Hayakawa; Katsumi Eguchi; Masami Niwa
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

8.  Naked TSH receptor DNA vaccination: A TH1 T cell response in which interferon-gamma production, rather than antibody, dominates the immune response in mice.

Authors:  P Pichurin; X M Yan; L Farilla; J Guo; G D Chazenbalk; B Rapoport; S M McLachlan
Journal:  Endocrinology       Date:  2001-08       Impact factor: 4.736

9.  Induction of experimental autoimmune Graves' disease in BALB/c mice.

Authors:  S Kaithamana; J Fan; Y Osuga; S G Liang; B S Prabhakar
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

10.  Immune deviation away from Th1 in interferon-gamma knockout mice does not enhance TSH receptor antibody production after naked DNA vaccination.

Authors:  Pavel Pichurin; Oxana Pichurina; Gregorio D Chazenbalk; Charmaine Paras; Chun-Rong Chen; Basil Rapoport; Sandra M McLachlan
Journal:  Endocrinology       Date:  2002-04       Impact factor: 4.736

View more
  4 in total

1.  Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice.

Authors:  J C Flynn; A Gardas; Q Wan; M Gora; G Alsharabi; W Z Wei; A A Giraldo; C S David; Y M Kong; J P Banga
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

2.  Thyroid antigens, not central tolerance, control responses to immunization in BALB/c versus C57BL/6 mice.

Authors:  Alexander V Misharin; Basil Rapoport; Sandra M McLachlan
Journal:  Thyroid       Date:  2009-05       Impact factor: 6.568

3.  A Novel Mouse Model of Autoimmune Thyroiditis Induced by Immunization with Adenovirus Containing Full-Length Thyroglobulin cDNA: Implications to Genetic Studies of Thyroid Autoimmunity.

Authors:  Larissa C Faustino; Cheuk W Li; Mihaela Stefan-Lifshitz; Kookjoo Kim; Oliver B Clarke; Yaron Tomer
Journal:  Thyroid       Date:  2020-05-19       Impact factor: 6.568

4.  cDNA immunization of mice with human thyroglobulin generates both humoral and T cell responses: a novel model of thyroid autoimmunity.

Authors:  Eric M Jacobson; Erlinda Concepcion; Kenneth Ho; Peter Kopp; Jussara Vono Toniolo; Yaron Tomer
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.